New drug ADCE-B05 targets Hard-to-Treat cancers in first human trial
NCT ID NCT07362888
First seen Jan 27, 2026 · Last updated May 14, 2026 · Updated 21 times
Summary
This early-phase study tests a new drug called ADCE-B05 in people with advanced solid tumors that have not responded to other treatments. The main goals are to find the safest dose and to check for side effects. About 180 adults will take part, and the drug is given alone at different dose levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMORS (PHASE 1) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Highlands Oncology Group
RECRUITINGSpringdale, Arkansas, 72762, United States
-
Monash Health
NOT_YET_RECRUITINGClayton, South Australia, 3165, Australia
-
Peter MacCallum Cancer Centre
NOT_YET_RECRUITINGMelbourne, Victoria, 3000, Australia
-
Scientia Clinical Research
RECRUITINGRandwick, New South Wales, 2031, Australia
-
Southern Oncology Clinical Research Unit
RECRUITINGBedford Park, South Australia, 5042, Australia
-
University Of Texas MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
Yale University
NOT_YET_RECRUITINGNew Haven, Connecticut, 06520, United States
Conditions
Explore the condition pages connected to this study.